EONS 2018 | Cancer nurse’s knowledge about biosimilars is critical

As biosimilar products are increasingly prevalent in oncology, there is a need for all of those involved in the care of patient’s using these products to have a good knowledge of biosimilars. Here, Johan De Munter, RN, of the University Hospital Ghent, Ghent, Belgium, discusses the critical need for nurse education about biosimilars. This interview took place at the European Oncology Nursing Society (EONS) and European Society for Medical Oncology (ESMO) Congress 2018, in Munich, Germany.